BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/30/2024 9:49:59 AM | Browse: 196 | Download: 655
 |
Received |
|
2024-08-23 02:47 |
|
Peer-Review Started |
|
2024-05-31 13:14 |
|
First Decision by Editorial Office Director |
|
2024-10-19 04:39 |
|
Return for Revision |
|
2024-10-19 04:39 |
|
Revised |
|
2024-11-02 01:57 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-12-09 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-09 06:31 |
|
Articles in Press |
|
2024-12-09 06:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-12-20 06:29 |
|
Publish the Manuscript Online |
|
2024-12-30 09:49 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Qin Pan, Qing-Yang Xu, Lang-Hua Zhang and Ya-Fang He |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Science and Technology Major Project of China |
2023ZD0508700 |
| National Natural Science Foundation of China |
81470859 |
| Program of Taizhou Science and Technology Grant |
24ywb33 |
|
| Corresponding Author |
Ya-Fang He, PhD, Department of Pediatric Respiratory, Xinhua Hospital, Shanghai Jiao Tong University, School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China. heyafang@xinhuamed.com.cn |
| Key Words |
Nonalcoholic fatty liver disease; Lung; Cancer; Adenocarcinoma; Metabolic syndrome; Component |
| Core Tip |
The increasing incidence of nonalcoholic fatty liver disease (NAFLD) has led to a public health burden, which is even worse due to its close association with lung cancer. Limited understanding of this phenomenon hinders the prevention, diagnosis, and treatment of NAFLD-related lung cancer. This article presents the effects of NAFLD on the progression, pathological subtypes, metastasis, and treatment response of lung cancer. Moreover, the mechanisms underlying the NAFLD-related metabolic disorders, metabolic syndrome-dependent immune impairment and tumor growth are discussed. These findings may provide insights into the role of NAFLD in pulmonary carcinoma, and highlights new treatment strategies for this disease. |
| Publish Date |
2024-12-30 09:49 |
| Citation |
Pan Q, Xu QY, Zhang LH, He YF. What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? World J Gastroenterol 2025; 31(5): 97500 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i5/97500.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i5.97500 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
